Tau Beta Pi

alwaysAI Announces Strategic Partnership With Dr. Gabriel A. Silva, Professor of Neuroscience and Bioengineering at the University of California San Diego

Retrieved on: 
Monday, November 27, 2023

SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- alwaysAI, a computer vision solutions leader, announces their partnership with Dr. Gabriel Silva, Professor of Neurosciences and Bioengineering at UCSD.

Key Points: 
  • SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- alwaysAI, a computer vision solutions leader, announces their partnership with Dr. Gabriel Silva, Professor of Neurosciences and Bioengineering at UCSD.
  • As a world-leading expert in neuroscience and machine learning, Dr. Silva will collaborate with alwaysAI to further advance their computer vision technology and solutions.
  • His cutting-edge research on how the brain processes vision and recognizes objects is helping push the boundaries of computer vision and machine learning.
  • “We are thrilled to work with Dr. Silva to further strengthen the alwaysAI platform,” said Marty Beard, Co-Founder and CEO of alwaysAI.

Award-Winning Pharmacist and Biopharmaceutical Entrepreneur Dr. David Dalton Honored with "BANNERED HERO" Award from Sigma Pi Phi Fraternity

Retrieved on: 
Saturday, October 14, 2023

HARRISBURG, Pa., Oct. 13, 2023 /PRNewswire/ -- Dr. David Dalton, an award-winning pharmacist and biopharmaceutical entrepreneur, was recently recognized as one of twelve 'BANNERED HEROES' at a celebration for Pennsylvania's African American Veterans hosted by The State Museum of Pennsylvania and Sigma Pi Phi Fraternity.

Key Points: 
  • In partnership with the State Museum of Pennsylvania, BANNERED HEROES is sponsored by the Beta Pi Boulé Chapter (Harrisburg, PA) of Sigma Pi Phi Fraternity (the Boulé), of which Dr. Dalton is a member.
  • Young, Colin Powell, James E. Clyburn, John Lewis, Wynton Marsalis, Barak Obama, Kenneth Chenault and Wes Moore, among others.
  • The Boulé is committed to elevating Black communities by striving to eliminate barriers to civic, social, political, educational and economic well-being.
  • Dr. Dalton is also one of the 18 veterans to have a banner hanging in Pennsylvania's Soldiers Grove, located behind the capitol.

DIPRA Welcomes Janine M. Alexander as Senior Regional Engineer

Retrieved on: 
Thursday, March 23, 2023

BIRMINGHAM, Ala., March 23, 2023 /PRNewswire/ -- The Ductile Iron Pipe Research Association (DIPRA) welcomes Janine M. Alexander, P.E. as the Senior Regional Engineer for the Southeastern States.

Key Points: 
  • Janine Alexander Brings 26+ Years' Experience to Her Work with Southeastern States' Water, Utility Professionals
    BIRMINGHAM, Ala., March 23, 2023 /PRNewswire/ -- The Ductile Iron Pipe Research Association (DIPRA) welcomes Janine M. Alexander, P.E.
  • as the Senior Regional Engineer for the Southeastern States.
  • "Janine Alexander is a top professional engineer, and we couldn't be more excited to welcome her onboard with us at DIPRA," said association President Patrick J. Hogan.
  • As a Senior Regional Engineer, Janine will provide technical expertise to utility managers, engineers, and water system operators who have questions about all aspects related to the application of Ductile iron pipe.

Ambar Prajapati Releases Disruptive Study on AMQP Integration With NORM

Retrieved on: 
Tuesday, July 5, 2022

RFY announced the release of a ground-breaking study by the author and software engineer Ambar Prajapati on the Advanced Message Queuing Protocol (AMQP) integration with the Negative ACKnowledgment (NACK) Oriented Reliable Multicast (NORM) Protocol-based framework.

Key Points: 
  • RFY announced the release of a ground-breaking study by the author and software engineer Ambar Prajapati on the Advanced Message Queuing Protocol (AMQP) integration with the Negative ACKnowledgment (NACK) Oriented Reliable Multicast (NORM) Protocol-based framework.
  • The novel study outlines a key mechanism for streaming dynamic contents from AMQP compliant systems, to NORM multicast senders, to a large group of recipients over an IP-based network.
  • The study also marks the first time that the breakthrough has been covered in the form of historical, scientific literature.
  • Encoded binary messages utilizing AMQP are transported among compliant processes via the AMQP broker, router, and client systems.

Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors

Retrieved on: 
Friday, March 25, 2022

Mr. Derby brings more than two decades of experience and a proven track record within the biopharmaceutical industry with particular expertise in strategic drug repurposing. Having founded or co-founded seven biopharmaceutical companies, he most recently launched TardiMed Sciences LLC, a company creation and investment firm in the life sciences space. TardiMed has formed, capitalized and advanced three biopharmaceutical companies -- Timber Pharmaceuticals, Inc. (NYSE:TMBR), PaxMedica, Inc. and Anker Pharmaceuticals LLC -- through Phase 2 clinical trials. Mr. Derby served as Executive Chairman of the Board of Directors for all three companies. Prior to TardiMed, Mr. Derby co-founded Castle Creek Pharmaceuticals, which he built into a multi-product, late clinical stage company focused on treating rare and debilitating dermatologic conditions. He also founded Norphan Pharmaceuticals, a biopharmaceutical company focused on the development of drugs for orphan neurologic disease, which he led through its early stages prior to selling the company to Marathon Pharmaceuticals. Prior to founding and managing life sciences companies, Mr. Derby was with an early-stage private equity and investment advisory firm, Centerstone Partners, and was a venture capitalist with EGS Healthcare Capital Partners. Mr. Derby holds an M.B.A., with distinction, from New York University’s Stern School of Business, an M.S. in Neuroscience from the University of Rochester, and a B.S., with honors, from Johns Hopkins University, where he was a Beneficial Hodson merit scholar and member of the Tau Beta Pi engineering honor society.

Key Points: 
  • LAVAL, Quebec, March 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Acasti or the Company) (Nasdaq: ACST and TSX-V: ACST) today announces that it has appointed Michael L. Derby to its Board of Directors.
  • Mr. Derby brings more than two decades of experience and a proven track record within the biopharmaceutical industry with particular expertise in strategic drug repurposing.
  • Mr. Derby served as Executive Chairman of the Board of Directors for all three companies.
  • Acasti is an advanced-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases.